Jeonjinbio Co., Ltd. (KOSDAQ:110020)
2,405.00
+5.00 (0.21%)
Last updated: Mar 26, 2025
Jeonjinbio Revenue
In the year 2024, Jeonjinbio had annual revenue of 19.27B KRW with 22.91% growth. Jeonjinbio had revenue of 4.40B in the quarter ending December 31, 2024, a decrease of -13.50%.
Revenue
19.27B
Revenue Growth
+22.91%
P/S Ratio
1.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.56B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.27B | 3.59B | 22.91% |
Dec 31, 2023 | 15.68B | 7.89B | 101.18% |
Dec 31, 2022 | 7.79B | 4.58B | 142.48% |
Dec 31, 2021 | 3.21B | -652.23M | -16.87% |
Dec 31, 2020 | 3.87B | -82.35M | -2.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 66.19T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,547.32B |
Hyundai Motor Company | 175.23T |
Celltrion | 3,557.30B |
Kia Corporation | 107.45T |
KB Financial Group | 15.01T |